Coronavirus
-

UK imposes more curbs after new strain of coronavirus found that ‘can spread more quickly’
Scroll Staff
-

Coronavirus: Centre needs to protect vaccine makers against lawsuits, says Serum Institute chief
Scroll Staff
-

Coronavirus: India’s count crosses 1-crore mark, toll over 1.45 lakh
Scroll Staff
-

Supply-chain ideas practiced by Amazon and Walmart can help reduce waste of Covid-19 vaccines
Tinglong Dai, The Conversation Christopher S Tang, The Conversation
-

Coronavirus: US Vice President Mike Pence, his wife receive Pfizer’s vaccine shots
Scroll Staff
-

Coronavirus ‘spread like wildfire’ due to poor implementation of guidelines, says Supreme Court
Scroll Staff
-

Coronavirus vaccination is voluntary, says health ministry in new document
Scroll Staff
-

Coronavirus: Coca Cola to cut 2,200 jobs globally, downsizing to impact 2.6% of the workforce
Scroll Staff
-

Teams should opt for big squads to deal with players’ bubble fatigue, says Ian Chappell
AFP
-

Coronavirus: FDA advisory panel recommends emergency use authorisation of Moderna vaccine
Scroll Staff
-

Coronavirus: Early trial data show Oxford vaccine evoked good response when given in 2-dose regime
Scroll Staff
-

Cricket in South Africa halted after 10 members of Test squad for Sri Lanka get exposed to Covid-19
AFP
-

Coronavirus: Supreme Court says affordable treatment a fundamental right amid rising cost
Scroll Staff
-

No amount of government intervention enough to deal Covid-19’s impact on economy: Nirmala Sitharaman
Scroll Staff
-

The big news: SC says farmers have a constitutional right to protest, and nine other top stories
Scroll Staff
-

Coronavirus: French President Emmanuel Macron tests positive, PM Modi wishes him speedy recovery
Scroll Staff
-

Christmas 2020: For this year’s festive decorations in Bolivia, baby Jesus comes with a face mask
Scroll Staff
-

Coronavirus: Delhi reports 1,363 new cases, record 90,354 tests conducted on Wednesday
Scroll Staff
-

Australian Open: Start of 2021's first Grand Slam delayed, set to begin on February 8
AFP
-

Covaxin induces strong immune response, no serious adverse effects in phase 1 trial: Bharat Biotech
Scroll Staff